Johnson & Johnson (JNJ) Stock Forecast & Price Target

$152.36 -0.64 (-0.42%)

(As of 12:09 PM ET)

Johnson & Johnson - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 15 Analyst Ratings

Sell
0

Hold
7

Buy
8

Based on 15 Wall Street analysts who have issued ratings for Johnson & Johnson in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 7 have given a hold rating, and 8 have given a buy rating for JNJ.

Consensus Price Target

$175.94
15.47% Upside

According to the 15 analysts' twelve-month price targets for Johnson & Johnson, the average price target is $175.94. The highest price target for JNJ is $215.00, while the lowest price target for JNJ is $150.00. The average price target represents a forecasted upside of 15.47% from the current price of $152.36.

JNJ Analyst Ratings Over Time

Type	Current Forecast 11/21/23 to 11/20/24	1 Month Ago 10/22/23 to 10/21/24	3 Months Ago 8/23/23 to 8/22/24	1 Year Ago 11/21/22 to 11/21/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	8 Buy rating(s)	7 Buy rating(s)	6 Buy rating(s)	6 Buy rating(s)
Hold	7 Hold rating(s)	6 Hold rating(s)	7 Hold rating(s)	8 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$175.94	$175.93	$173.21	$169.19
Forecasted Upside	15.47% Upside	8.03% Upside	6.69% Upside	11.94% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Hold	Hold

This thing would have won 534 of the 550 trades placed in the last 11 years (Ad)

Choosing what your next move will be is one of the most difficult choices investors are faced with today — especially in turbulent markets like these. But what if there was one technique that checked all these boxes? ✅ Allows traders of all stripes to target extra income week after week ✅ Won 534 of 550 trades according to our backtesting on 11-years worth of data ✅ Has maintained a shocking 97.1% through every market condition imaginable ✅ Sets up “Weekly Windfalls” every week so that it’s never trading opposite the broad market direction Well, we’re here to tell you, that strategy isn’t a pipe dream… It’s the same flagship strategy Chris Pulver just released an urgent briefing on! And your friends at Prosperity Pub have secured the video just for you. And with the very next trade dropping THIS WEEK you couldn't have better timing! While we cannot promise future returns or against losses, you have to…

While we cannot promise future returns or against losses, you have to… Check out this training ses

JNJ Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

JNJ Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Johnson & Johnson Stock vs. The Competition

Type	Johnson & Johnson	Medical Companies	S&P 500
Consensus Rating Score	2.53	2.80	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	15.29% Upside	26,825.32% Upside	10.39% Upside
News Sentiment Rating	Positive News See Recent JNJ News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/15/2024	Wolfe Research 3 of 5 stars	A. Hammond Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$190.00	+25.12%
11/6/2024	Guggenheim 3 of 5 stars		Boost Target	Neutral ➝ Neutral	$156.00 ➝ $162.00	+2.40%
10/16/2024	Citigroup 3 of 5 stars		Boost Target	Buy ➝ Buy	$180.00 ➝ $185.00	+12.43%
10/16/2024	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$215.00 ➝ $215.00	+30.70%
10/16/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$163.00 ➝ $166.00	+0.91%
10/16/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$178.00 ➝ $181.00	+10.28%
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad) As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now!
10/16/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$169.00 ➝ $175.00	+6.62%
7/23/2024	Daiwa America Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Nakagiri Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
7/23/2024	Daiwa Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Neutral	$160.00 ➝ $150.00	-2.75%
7/19/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$160.00 ➝ $155.00	+0.27%
7/18/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$161.00 ➝ $171.00	+9.10%
7/18/2024	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$195.00 ➝ $185.00	+18.03%
7/18/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$195.00 ➝ $185.00	+18.38%
4/18/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$169.00 ➝ $170.00	+17.43%
4/17/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$180.00 ➝ $170.00	+17.96%
1/3/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$172.00 ➝ $175.00	+8.93%
12/1/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$167.00 ➝ $180.00	+16.39%
10/12/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$158.00 ➝ $162.00	+3.73%
8/4/2023	Atlantic Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$167.00 ➝ $170.00	-0.42%
7/21/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral	$175.00 ➝ $180.00	+5.75%
7/21/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$165.00 ➝ $175.00	+3.92%
7/21/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral	$170.00 ➝ $175.00	+3.92%
2/6/2023	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$55.00 ➝ $52.00	-68.17%
1/20/2023	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$194.00 ➝ $186.00	+9.72%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 12:26 PM ET.

Should I Buy Johnson & Johnson Stock? JNJ Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, November 6, 2024. Please send any questions or comments about these Johnson & Johnson pros and cons to contact@marketbeat.com.

Johnson & Johnson
Bull Case

Here are some ways that investors could benefit from investing in Johnson & Johnson:

Johnson & Johnson has a strong market capitalization of $385.77 billion, indicating stability and size in the market.
Recent increase in institutional ownership to 69.55% of the company's stock, showing confidence from large investors.
Consistent dividend payments over the years, providing investors with a reliable income stream.
Positive analyst ratings with an average of "Moderate Buy" and a consensus price target of $173.21, suggesting growth potential.
Current stock price of $160.29, potentially offering a good entry point for investors looking for value.

Johnson & Johnson
Bear Case

Investors should be bearish about investing in Johnson & Johnson for these reasons:

Recent target price decrease by TD Securities from $195.00 to $185.00, indicating potential concerns in the market.
Multiple analyst downgrades from "strong-buy" to "hold," suggesting a shift in sentiment towards the company.
Competition in the healthcare field leading to pricing pressures and regulatory challenges for Johnson & Johnson.
Market volatility and economic uncertainties impacting the healthcare sector, affecting Johnson & Johnson's performance.
Potential impact of global events and health crises on the company's operations and financial results.

JNJ Forecast - Frequently Asked Questions

: According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Johnson & Johnson is $175.94, with a high forecast of $215.00 and a low forecast of $150.00.
: 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Johnson & Johnson in the last twelve months. There are currently 7 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" JNJ shares.
: According to analysts, Johnson & Johnson's stock has a predicted upside of 15.47% based on their 12-month stock forecasts.
: Johnson & Johnson has been rated by research analysts at Cantor Fitzgerald, Citigroup, Guggenheim, Morgan Stanley, Royal Bank of Canada, Wells Fargo & Company, and Wolfe Research in the past 90 days.
: Analysts like Johnson & Johnson less than other "medical" companies. The consensus rating score for Johnson & Johnson is 2.53 while the average consensus rating score for "medical" companies is 2.80. Learn more on how JNJ compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

Claim your FREE 2024 Gold Guide

This page (NYSE:JNJ) was last updated on 11/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Johnson & Johnson (JNJ) Stock Forecast & Price Target